Bristol-Myers Squibb

Princeton, New Jersey 08540-4715

0 studies enrolling now · 7 studies all time

What they study most

Advanced Melanoma, Heart Decompensation, Melanoma, Myelodysplastic Syndromes (MDS), Renal Cell Carcinoma

Studies at this site

• Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Database — Completed
• A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept — Running, not enrolling
• Study of the Sudden Heart Failure Participant Population in the US — Withdrawn before enrolling
• Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread — Completed
• Healthcare Cost and Resource Utilization Related to Metastatic Renal Cell Carcinoma Treatment With Intravenous and Oral Agents — Withdrawn before enrolling
• Study of Autoimmune Disease Complications Following Ipilimumab Treatment Among Melanoma Patients With Underlying Autoimmune Diseases — Completed
• YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey — Completed